Online, On-Demand Recording
Class description
Occupational and environmental health exposures cause thousands of illnesses and injuries each year. This lecture series addresses the evaluation, treatment, and prevention of disease and injuries related to environmental and occupational exposures encountered by physicians and their colleagues in local, regional, and international settings.
On-Demand, Online Recording of Live Lecture from April 17, 2023
OEM Grand Rounds - Chronic Low Back Pain: An Interventional Spine Approach
Presenter: Virtaj Singh, MD, Medical Director, Seattle Spine and Sports Medicine; Clinical Faculty, University of Washington, Department of Rehabilitation Medicine
View the OEM Grand Rounds Lecture Series flyer.
On-demand online recording available NOW through 5/23/25.
LECTURE OVERVIEW
Dr. Singh’s lecture discussed how to approach chronic low back pain from an interventional and occupational health perspective. He discusses the various anatomic structures that can contribute to low back pain and interventions that can help identify and treat those structures. Dr. Singh, who treats injured workers, collaborates with several types of practitioners during the treatment process, including occupational, massage, physical therapists; chiropractors; surgeons; primary care providers and vocational and case management services.
PRESENTER BIO
Dr. Virtaj Singh, MD is a physiatrist with extensive training in electrodiagnostic medicine and is fellowship-trained in the use of fluoroscopically-guided spinal injections for cervical and lumbar disorders, ultrasound-guided injections for the treatment of peripheral joint disorders, intramuscular stimulation (dry needling), trigger point injections, prolotherapy and platelet rich plasma injections. Dr. Singh earned his medical degree from Baylor College of Medicine and completed his residency in Physical Medicine and Rehabilitation at the University of Washington. Following residency, he completed a fellowship in Pain Medicine at the University of Washington. Dr. Singh is committed to providing compassionate care for patients with a wide range of ailments, using a comprehensive approach to diagnosis and treatment.
ACCREDITATION
In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention and the Northwest Center for Occupational Health and Sciences, University of Washington Department of Environmental and Occupational Health Sciences. The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA CME: Credit Designation Statement – Enduring Materials
The Centers for Disease Control and Prevention has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME credits. Approval is valid until {May 23, 2025}. PAs should only claim credit commensurate with the extent of their participation.
CNE: The Centers for Disease Control and Prevention designates this activity for 1.25 nursing contact hours.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.
DISCLOSURE: In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies during the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.
CDC, our planners, and content experts wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Dr. Jennifer M Zumsteg’s discussion of Traumatic Brain Injury. She will be discussing current treatments for TBI, none which are FDA approved medications for symptom management. Therefore, the information that the treatments are “off-label.”
If CEU only, Joint Provider: The Centers for Disease Control and Prevention and Northwest Center for Occupational Health and Safety are jointly providing the CEUs for this activity.
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.